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Abstract
Background: Arteriovenous Fistula (AVF) is the ideal method of vascular access for patients on
maintenance hemodialysis (HD). Therefore it is an important part of treatment in HD. There are sev-
eral observations that indicate the role of inflammation in failure of AVF. The aim of this study was
to evaluate the hematologic and inflammatory biomarkers in early AVF failure.
Methods: This case-control study included 110 ESRD patients, whom were undergone AVF crea-
tion, divided in two groups. About 700 radius-cephalic AVF were created during these two years.
We found 55 cases with AVF failure. In this study, we compared those 55 failures with 55 functional
AVF which were selected using randomized sampling from the rest of patients according to age,
gender, and AVF location. Levels of serum C-reactive protein (CRP) were checked in both groups to
evaluate the relation between AVF failure and CRP level before surgery.
Results: The mean±SD age of the patients was 49.7±17.28 years. CRP was positive in 34 patients
(61.8%) with unsuccessful fistula function, while only 4 (7.3%) of those with successful AVF had
positive CRP and the rest had negative CRP. The difference between the two groups of patients was
strongly significant (p<0.001). Statistically, there was not any significant difference between the av-
erage of age (p: 0.580) of patients in the control and experimental groups. However, the gender (p:
0.832) discrepancies was not meaningful between the groups.
Conclusion: AVF thrombosis is one of the main complications after AVF creation. Therefore, it is
recommended to check CRP before AVF surgery to prevent possible failure of the fistula function.
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Introduction
With large advances during recent years
in medicine and general heath, the life span
of ESRD patients has been increased (1).
New studies show that the prevalence of
ESRD patients is increasing 7-9% each
year (2, 3)
Hemodialysis (HD) is the most common
renal replacement procedure performed for
end stage renal disease (ESRD) patients
(4). Vascular Access is the most important
medical procedure in these cases.
Nowadays, AVF is one of the most com-
mon Vascular Access for HD (5). Vascular
access failure and its complications are the
most frequent hospital admission cause in
these patients. In overall, dialysis grafts,
that are not frequent in Iran, last shorter
than AVF and are more prone to infection
and thrombosis (6).
At clinical level, early failure has been
defined as an AVF that never develops ad-
equately for dialysis (failure to mature), or
which fails within one month of starting
dialysis. As identified, increased age, fe-
male gender, high blood pressure, presence
of diabetes, Caucasian race, vasculature
diseases and hemodynamic profile may
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complicate the prognosis of AVF (7).
Technical errors in AVF creation are the
main causes of early AVF failure (8). Fac-
tors such as low hemoglobin levels and
high calcium and phosphorous concentra-
tions have been demonstrated as other
causes of early AVF failure. Likewise heart
failure, distal ischemia, aneurysm for-
mation, median nerve injury, local bleed-
ing, venous hypertension and Steal’s syn-
drome can be some other probable sources
of the complications (9-10).
Thrombosis in the arteriovenous anasto-
mosis is a common complication. (11-12)
In addition, there are some other risk fac-
tors that can influence physiopathology of
vascular access destruction (13). So far,
there are not many studies relating clinical
factors and biomarkers to AVF failure, and
furthermore, there are many controversies
in these studies. A study in the UK had
concluded that low Albumin levels could
be a risk factor for AVF failure (14). An-
other study demonstrated low hemoglobin
levels as a destructive factor (9). However,
all studies have suspected the importance of
inflammatory process. Furthermore, there
are not many studies regarding inflammato-
ry biomarkers and AVF failure. The rela-
tion between hemoglobin, Albumin, in-
flammation and other biomarkers are still
unclear (9, 11-13). Thus, finding clinical
and para clinical factors that can indicate
early and late failure of the fistula is essen-
tial (14-16). In our study, we evaluated the
relationship between inflammation bi-
omarker (CRP) and early rejection of AVF
in ESRD patients.
Methods
Subjects
This is a case-control study of patients
who were all candidates of fistula creation
and hospitalized at Hasheminejad Kidney
Center as a referral kidney hospital between
December 2010 and October 2012. About
700 radius-cephalic AVF were done during
these two years and we had 55 failure. In
this study we compared those 55 failures to
another 55 functional AVF which were se-
lected using randomized sampling from the
rest of patients according to their age, gen-
der, and AVF site.
The study and analysis included 55 ESRD
patients with functional AVF and 55 others
who experienced failure due to AVF
thrombosis during one month after surgery.
Therefore, we classified the 55 patients
with AVF dysfunction as ‘Failure’ and
those 55 with successful AVF creation as
‘Survived’ groups. Data related to age,
gender and AVF complication was also an-
alyzed.
The demographic data and other related
information were recorded on a checklist
paper. CRP levels were recorded as well.
Other complications related to the AVF
were also assessed in the study.
Blood sample assays
Blood samples were obtained before the
AVF surgery from antecubital vein of the
opposite hand. All Biochemical assays
were carried out in the Hasheminejad Kid-
ney Center laboratory. CRP levels were
measured with high sensitive CRP (hs-
CRP) assay based on the principle of a sol-
id phase Enzyme-linked immunosorbent
assay (ELISA) using goat anti Human CRP
antibody (hs-CRP ELISA kit, DRG Instru-
ment GmbH, Germany). The intra- and in-
ter-assay coefficients of variation (CV) are
both under 5%. All CRP levels higher than
200 nm/L were considered as positive val-
ues.
Statistical analysis
Descriptive statistics such as mean and
standard deviation were used. Independent
T-test was used to analyze quantitative da-
ta. Chi-square test was used for qualitative
data.
Ethical issues
Patients were given information on the
goal and subject of the study; oral approval
for their participation as a subject of study
were also gained. The participants’ infor-
mation kept confidential. The protocol of
the study gained the approval of the Tehran
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University of Medical Sciences Institution-
al board review.
Results
In this study, 110 ESRD patients under-
went AVF creation surgery. The mean±SD
age of the patients was 50.62 ±16.7 years.
The case group included 55 patients who
experienced AVF failure because of throm-
bosis. The control (survived) group includ-
ed 55 patients, whose AVF installations
were successful. Variables such as age,
gender and CRP levels were also studied in
both groups.
Thirty one cases (28.2%) were female and
79 (71.8%) were male. Among all the pa-
tients, 54 (49.1%) had diabetes and 60 pa-
tients (54.5%) had hypertension. Of all cas-
es, 38 (34.5%) were CRP positive and 72
(65.5%) were CRP negative.
Surgery was performed at the radius-
cephalic area, including 11.5% side to side
and 88.5% end to side anastomosis. 93% of
the AVFs were created in the left hand.
None of the patients showed infection,
hemorrhage or pseudo aneurysm. Site of
AVF (left or right hand) also had no differ-
ence in both groups (p: 1.000).
Mean±SD of age and hemoglobin level
(Hb) were 49.75±17.28 and 8.7 ±1.33, re-
spectively. According to the t-test analysis,
Hb level and age had no statistical differ-
ence between the failure and survived
groups (p: 1.000 &0.549 respectively).
Thirty nine cases (70.1%) of thefailure
group were male and 29.1% were female.
However, the gender of participants
showed no meaningful difference in the
success or failure of their AVFs (p: 0.832).
Diabetes and hypertension had no statistical
difference between the failure and survived
groups (p: 1.000 in both groups) (Table 1).
Chi Square analysis showed meaningful
relation between failure of AVF and CRP
status of the patients (sig: 0.000) in the
failure group (55 patients).
Within the 55 patients who experienced
failure in the AVF function, 34 (61.8%)
were CRP positive; Only 4 (7.3%) with
positive CRP had successful AVF creation
(p<0.001) (Table 2).
In the logistic regression analysis, age,
sex, diabetes, Hb level, hypertension and
CRP status effects on failure of AVF were
evaluated; CRP (+/-) had statistical signifi-
cance (p<0.001) in this analysis (Table 3).
Table 1. Comparison  of  different  variables  between  survived  and  control  groups
Variable Case
N(%)
Control
N(%)
p
Gender (male) 39/55(70.9%) 40/55(72.7%) 0.832
DM positive 27/55(49.1%) 27/55(49.1%) 1.000
Hypertension 30/55(54.5%) 30/55(54.5%) 1.000
CRP + 34/55(61.8%) 4/55(7.3%) 0.000
Table 2. Frequency  distribution of  CRP  status  in  survived  and  failure  group
Failure Category N %
No (survived Group) no 51 92.7
yes 4 7.3
Total 55 100.0
Yes (Failure Group) no 21 38.2
yes 34 61.8
Total 55 100.0
Table 3. Results from logistic regression
Variable B SE p OR 95% CI for OR
Lower Upper
Age -0.003 0.015 0.818 0.997 0.968 1.026
Sex -0.358 0.522 0.493 0.699 0.251 1.947
diabetes 0.220 0.493 0.656 1.246 0.474 3.277
hb -0.163 0.184 0.377 0.850 0.592 1.219
htn -0.110 0.480 0.818 0.896 0.349 2.295
CRP 3.174 0.615 <0.001 23.896 7.161 79.735
CRP and AV fistula failure
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Discussion
General findings: In our study, the mean
age of our subjects was 53.27±17.47 years,
generally lower than other studies in west-
ern countries (17-18).
In a study in the 90s, 11% of patients had
suffered from AVF thrombosis (19). An-
other study in 2011 showed that 23% of
thrombosis was occurred in malnutrition
patients, which points to the probability of
lower albumin level association with higher
AVF loss in that study. There has been
some higher rates of unsuccessful AVFs in
some other studies, in which they have re-
ported much larger rates of other complica-
tions, such as infection and psuedoaneu-
rysm (7-9, 13, 20). Another study in Croa-
tia demonstrated that high blood pressure,
history of diabetes and HD duration is re-
lated to long term AVF inefficiency (17).
The difference between those results and
our finding is probably due to shorter dura-
tion of follow-up and smaller sample size
in our study. However, in most of previous
studies (7-9), no significant difference was
seen within age, gender and history of dia-
betes groups, under the condition of early
AVF failure.
Inflammatory biomarker: In our study,
patients with AVF failure showed signifi-
cantly higher CRP levels. Roy-Chaudhury
was the first who found the role of inflam-
mation, following an invasive procedure
such as angiography, in AVF failure. The
study demonstrated the aggressive intimal
hyperplasia in anastomotic vessels is asso-
ciated with thrombotic closure of AVF, re-
sulting in AVF failure (21).
Another study showed an association be-
tween fibrinolytic/ endothelial cell function
and increased inflammatory biomarkers
(fibrinogen and CRP) in ESRD patients
(22).
There are some other studies with con-
sistent results, which can work as positive
proof to our study. In a study, catheter in-
sertion and AV graft creation resulted in a
transient state of high CRP within first
postoperative week, while this was not ob-
served after AVF surgery (23, 24). In an-
other study, significantly lower hemoglobin
levels related to AVF failure in patients
was identified as a prognostic factor (25).
Furthermore, there are some studies
demonstrating association between low
hemoglobin levels and AVF failure (26,
27). Based on these evidences, it is very
likely that in ESRD patients low hemoglo-
bin levels induce local low grade inflamma-
tion, which can accelerate the thrombosis
formation in AVF site. Thus, seems likely
that patient with anemia to be more prone
to AVF thrombosis with high CRP as a
predictor biomarker, than other non-anemic
ones.
Conclusion
Our study suggests that inflammatory fac-
tors inducing thrombosis might be im-
portant causes of early AVF failure in
ESRD patients. CRP level is high in failed
AVF cases. Probably larger sample size
would further clarify the role of inflamma-
tory biomarkers in prognosis of AVF fail-
ure.
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